Tempus AI
TEM
70.35
-1.63
-2.26%
Tempus AI
US · TEM
#1138 by market cap
Listed 2024
70.35
-1.63
-2.26%
Live - 5344 symbols - heartbeat 54s ago
· 2026-10-08 06:48
Pre-market
68.90
-2.06%
After-hours
70.25
-0.14%
Overnight
69.29
-1.51%
- Market cap
- 12.69B
- P/E (TTM)i
- -48.85
- P/Bi
- 28.53
- EPSi
- -1.41
- Div yieldi
- 0.00%
- 52W posi
- 52%
Reader sentiment
Are you bullish or bearish on TEM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.41, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +83.41% YoY
Margins
- Gross margin
- 62.74%
- Operating margin
- -19.88%
- Net margin
- -19.27%
Key ratios & quality
- Enterprise valuei
- 13.19B
- Altman Z-Scorei
- 3.41
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 62.06M | 188.00M | 257.85M | 320.67M | 531.82M | 693.40M | 1.27B |
| Gross profit | 16.04M | 28.71M | 83.64M | 130.19M | 286.18M | 381.11M | 797.90M |
| Selling & admin expenses | 78.96M | 130.89M | 199.00M | 233.38M | 288.44M | 743.13M | 715.43M |
| Research & development | 56.86M | 91.28M | 128.35M | 162.25M | 185.50M | 316.84M | 319.03M |
| Operating profit | -119.78M | -193.45M | -243.71M | -265.44M | -196.08M | -691.08M | -252.87M |
| Pretax profit | -114.95M | -211.35M | -258.59M | -289.15M | -213.53M | -701.32M | -291.10M |
| Tax | 0 | 0 | 0 | 66.00K | 288.00K | 266.00K | -51.68M |
| Net profit | -114.95M | -209.85M | -259.19M | -289.81M | -214.12M | -705.81M | -245.03M |
| Basic EPS | -1 | -2 | -2 | -2 | -2 | -6 | -1 |
| Diluted EPS | -0.92 | -1.58 | -1.85 | -2.08 | -1.61 | -6.23 | -1.41 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 255.74M | 314.64M | 334.21M | 367.21M | 348.12M | 382.49M |
| Gross profit | 155.20M | 195.04M | 209.94M | 237.71M | 222.04M | 246.50M |
| Selling & admin expenses | 154.63M | 180.71M | 187.89M | 192.20M | 212.59M | 225.85M |
| Research & development | 69.27M | 76.10M | 83.05M | 90.62M | 94.16M | 96.57M |
| Operating profit | -68.69M | -61.77M | -61.00M | -61.41M | -84.71M | -75.91M |
| Pretax profit | -112.33M | -40.53M | -81.22M | -57.01M | -122.90M | 8.82M |
| Tax | -46.18M | 212.00K | 276.00K | -5.99M | -62.00K | 309.00K |
| Net profit | -68.04M | -42.84M | -79.98M | -54.17M | -125.92M | 5.64M |
| Basic EPS | 0 | 0 | 0 | 0 | -1 | 0 |
| Diluted EPS | -0.40 | -0.25 | -0.46 | -0.31 | -0.71 | 0.03 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 276.23M | 649.73M | 403.99M | 438.63M | 350.33M | 667.60M | 1.17B |
| Cash & ST investments | 227.60M | 513.44M | 277.69M | 302.94M | 197.57M | 448.26M | 755.00M |
| Inventory | 8.28M | 37.56M | 22.91M | 22.28M | 28.85M | 38.39M | 51.72M |
| Total assets | 370.17M | 751.92M | 531.35M | 631.36M | 564.05M | 926.12M | 2.27B |
| Total current liabilities | 43.73M | 101.38M | 114.81M | 174.24M | 232.63M | 291.07M | 372.39M |
| Short-term debt | 1.15M | 723.00K | 419.00K | 6.36M | 6.44M | 6.46M | 13.36M |
| Long-term debt | -- | 250.00M | 238.24M | 389.55M | 449.67M | 435.44M | 1.24B |
| Total liabilities | 624,586,000.00 | 1,264,902,000.00 | 1,338,845,000.00 | 1,760,391,000.00 | 1,946,215,000.00 | 869,777,000.00 | 1,783,512,000.00 |
| Total equity | -254.42M | -512.98M | -807.49M | -1.13B | -1.38B | 56.34M | 491.33M |
| Retained earnings | -257.85M | -512.99M | -807.49M | -1.14B | -1.40B | -2.15B | -2.40B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 573.97M | 644.20M | 1.15B | 1.17B | 1.05B | 1.29B |
| Cash & ST investments | 218.79M | 291.31M | 759.64M | 755.00M | 639.07M | 815.99M |
| Inventory | 50.49M | 47.60M | 54.98M | 51.72M | 51.83M | 53.51M |
| Total assets | 1.54B | 1.63B | 2.28B | 2.27B | 2.14B | 2.37B |
| Total current liabilities | 336.47M | 418.16M | 350.03M | 372.39M | 317.96M | 391.49M |
| Short-term debt | 9.42M | 9.38M | 12.42M | 13.36M | 12.64M | 12.19M |
| Long-term debt | 800.76M | 798.01M | 1.25B | 1.24B | 1.23B | 1.36B |
| Total liabilities | 1,216,943,000.00 | 1,315,803,000.00 | 1,773,600,000.00 | 1,783,512,000.00 | 1,718,686,000.00 | 1,920,977,000.00 |
| Total equity | 326.19M | 309.56M | 507.82M | 491.33M | 416.41M | 444.93M |
| Retained earnings | -2.22B | -2.26B | -2.34B | -2.40B | -2.52B | -2.52B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -117.11M | -206.56M | -211.98M | -168.20M | -214.34M | -189.05M | -218.09M |
| Depreciation & amortization | 15.02M | 23.05M | 23.88M | 30.41M | 33.33M | 37.25M | 102.32M |
| Free cash flow | -134.15M | -219.98M | -223.75M | -186.58M | -248.95M | -211.17M | -245.36M |
| Dividends paid | -5.29M | -5.63M | -5.63M | -5.63M | -5.63M | -5.63M | 0 |
| Stock buybacks / issuance | 10.20M | -7.31M | 0 | 0 | -3.60M | 381.95M | 192.46M |
| Ending cash balance | 228.10M | 514.22M | 278.47M | 303.73M | 166.61M | 341.84M | 609.45M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -105.62M | 44.16M | -119.84M | -36.79M | -73.28M | -7.53M |
| Depreciation & amortization | 20.35M | 28.03M | 27.03M | 26.91M | 26.18M | 25.99M |
| Free cash flow | -109.00M | 34.65M | -127.89M | -43.12M | -83.34M | -18.62M |
| Dividends paid | -- | -- | -- | 0 | -- | -- |
| Stock buybacks / issuance | -- | -- | 195.50M | -3.04M | -- | -- |
| Ending cash balance | 153.33M | 188.05M | 660.55M | 609.45M | 525.86M | 604.34M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- | -89.48 |
| ROA %i | -40.02 | -45.26 | -46.40 | -57.44 | -44.50 | -100.17 | -15.31 |
| ROIC %i | -- | -- | -- | -- | -- | -- | -16.87 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -185.19 | -102.35 | -94.40 | -83.34 | -31.34 | -93.40 | -17.36 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 6.32 | 6.41 | 3.52 | 2.52 | 1.51 | 2.29 | 3.13 |
| Quick ratioi | 5.93 | 5.93 | 3.14 | 2.25 | 1.26 | 2.07 | 2.89 |
| Debt / assetsi | 0.70 | 33.44 | 44.97 | 68.59 | 86.54 | 50.54 | 58.34 |
| LT debt / equityi | -- | -- | -- | -- | -- | 819.39 | 267.39 |
| Interest coveragei | -4,104.39 | -10.17 | -16.03 | -12.21 | -3.56 | -12.07 | -3.14 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 72.88 | 41.43 | 39.06 | 58.29 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -97.95 | -72.61 | -89.48 | -81.58 | -67.44 |
| ROA %i | -71.69 | -16.04 | -12.53 | -15.31 | -16.47 | -12.75 |
| ROIC %i | -- | -17.85 | -13.28 | -16.87 | -17.26 | -14.25 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -85.96 | -17.92 | -15.93 | -17.36 | -17.23 | -13.76 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.71 | 1.54 | 3.28 | 3.13 | 3.31 | 3.30 |
| Quick ratioi | 1.43 | 1.34 | 3.00 | 2.89 | 3.02 | 3.05 |
| Debt / assetsi | 55.58 | 52.50 | 58.55 | 58.34 | 61.76 | 61.04 |
| LT debt / equityi | 260.07 | 272.60 | 260.60 | 267.39 | 313.61 | 321.84 |
| Interest coveragei | -11.82 | -2.56 | -2.58 | -3.14 | -3.53 | -3.56 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 06:48:58 · For reference only, not investment advice and not tailored to your situation.